ING Groep NV Increases Stock Holdings in Healthpeak Properties, Inc. $DOC

ING Groep NV lifted its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 317.5% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 92,016 shares of the real estate investment trust’s stock after buying an additional 69,975 shares during the quarter. ING Groep NV’s holdings in Healthpeak Properties were worth $1,480,000 as of its most recent filing with the SEC.

Several other hedge funds have also modified their holdings of DOC. WPG Advisers LLC raised its holdings in shares of Healthpeak Properties by 270.2% during the 4th quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock valued at $26,000 after buying an additional 1,197 shares during the period. Elyxium Wealth LLC purchased a new stake in Healthpeak Properties during the 4th quarter worth approximately $31,000. Clearstead Advisors LLC raised its position in shares of Healthpeak Properties by 166.3% in the 4th quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock valued at $31,000 after purchasing an additional 1,216 shares in the last quarter. CYBER HORNET ETFs LLC purchased a new position in shares of Healthpeak Properties during the 2nd quarter valued at approximately $33,000. Finally, Wiser Advisor Group LLC purchased a new position in shares of Healthpeak Properties during the 3rd quarter valued at approximately $38,000. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

DOC has been the subject of a number of research analyst reports. Royal Bank Of Canada lifted their price target on shares of Healthpeak Properties from $20.00 to $21.00 and gave the stock an “outperform” rating in a research note on Thursday, May 14th. Robert W. Baird raised their price objective on shares of Healthpeak Properties from $19.00 to $21.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. UBS Group boosted their target price on shares of Healthpeak Properties from $17.00 to $19.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 13th. Wells Fargo & Company upped their target price on shares of Healthpeak Properties from $18.00 to $20.00 and gave the company an “equal weight” rating in a research note on Monday, June 1st. Finally, Citigroup increased their price target on shares of Healthpeak Properties from $17.50 to $20.00 and gave the stock a “neutral” rating in a research report on Tuesday, May 12th. Four research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to MarketBeat.com, Healthpeak Properties presently has an average rating of “Hold” and a consensus price target of $19.38.

Insiders Place Their Bets

In related news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total value of $213,736.05. Following the sale, the insider directly owned 7,636 shares in the company, valued at $148,520.20. This trade represents a 59.00% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.23% of the stock is currently owned by corporate insiders.

Healthpeak Properties Trading Up 3.6%

Shares of NYSE:DOC opened at $20.48 on Wednesday. The company has a market cap of $14.12 billion, a PE ratio of 64.01, a P/E/G ratio of 3.09 and a beta of 1.05. The company’s 50-day moving average price is $18.10 and its 200 day moving average price is $17.43. Healthpeak Properties, Inc. has a fifty-two week low of $15.70 and a fifty-two week high of $20.70. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.02. The firm had revenue of $752.95 million for the quarter, compared to the consensus estimate of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. Healthpeak Properties’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same period last year, the firm posted $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Sell-side analysts anticipate that Healthpeak Properties, Inc. will post 1.74 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Friday, June 26th. Investors of record on Monday, June 15th will be given a $0.1017 dividend. The ex-dividend date is Monday, June 15th. This represents a c) annualized dividend and a yield of 6.0%. Healthpeak Properties’s dividend payout ratio (DPR) is currently 381.25%.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.